Consumers Taking GLP-1s for Weight Loss, Current or Discontinued, Drive Lasting Changes in Retail, Per New Acosta Group Study News provided by Acosta Group Apr 14, 2025, 12:05 ET 76% of those who discontinued GLP-1s are eating the same amount or less and many report retaining healthy habits JACKSONVILLE, Fla., April 14, 2025 /PRNewswire/ -- In advance of the National Association of Chain Drug Stores (NACDS) Annual Meeting, Acosta Group is sharing the results of its recent proprietary GLP-1 Shopper Community study, focusing on consumers using the medications specifically to support weight loss
2019 Nov 22;24(23):4262
Sleep deprivation and chronic stress can slow weight loss by elevating cortisol and insulin, counteracting the medication's benefits
BPC-157 mechanism of action: How it works in your body Understanding BPC-157s mechanisms of action can give you an idea of why this peptide has become so popular for healing and recovery
Novo Nordisk, the maker of Wegovy, said in a statement, patient safety was the top priority and all reports of adverse events were taken seriously
Unwavering Commitment to Safety: Your health is our absolute priority